Atropine pretreatment enhances airway hyperreactivity in antigen-challenged guinea pigs through an eosinophil-dependent mechanism

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 292, Issue 5, 2007, Pages

  Verbout, Norah G ^a   Lorton, Jesse K ^a   Jacoby, David B ^a   Fryer, Allison D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anticholinergic; Asthma; Muscarinic receptors; Parasympathetic nerves

Indexed keywords

ACETYLCHOLINE; ANTIGEN; ATROPINE; INTERLEUKIN 5 ANTIBODY; MAJOR BASIC PROTEIN; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIZATION; ELECTROSTIMULATION; EOSINOPHIL; FEMALE; GUINEA PIG; HYPERSENSITIVITY REACTION; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVOCATION TEST; VAGUS NERVE STIMULATION;

ANIMALS; ANTIGENS; ATROPINE; BRADYCARDIA; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; GUINEA PIGS; IMMUNIZATION; RECEPTORS, MUSCARINIC;

EID: 34249807385     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00455.2006     Document Type: Article

References (72)

1. Ayala LE, Ahmed T. Is their loss of protective muscarinic receptor mechanism in asthma? Chest 96: 1285-1291, 1989.
2. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P. Eosinophilic inflammation in asthma. N Engl J Med 323: 1033-1039, 1990.
3. Brophy C, Ahmed B, Bayston S, Arnold A, McGivern D, Greenstone M. How long should Atrovent be given in acute asthma? Thorax 53: 363-367, 1998.
4. Cazzola M, Centanni S, Donner CF. Anticholinergic agents. Pulm Pharmacol Ther 11: 381-392, 1998.
5. Chand N, Harrison JE, Rooney S, Pillar J, Jakubicki R, Nolan K, Diamantis W, Sofia RD. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur J Pharmacol 211: 121-123, 1992.
6. Costello RW, Jacoby DB, Gleich GJ, Fryer AD. Eosinophils and airway nerves in asthma. Histol Histopathol 15: 861-868, 2000.
7. 2 muscarinic receptor function. Am J Physiol Lung Cell Mol Physiol 273: L93-L103, 1997.
8. Cropp GJ. The role of the parasympathetic nervous system in the maintenance of chronic airway obstruction in asthmatic children. Am Rev Respir Dis 112: 599-605, 1975.
9. Drazen JM, Austen KF. Atropine modification of the pulmonary effects of chemical mediators in the guinea pig. J Appl Physiol 38: 834-838, 1975.
10. 2 muscarinic receptor function in antigen-challenged guinea pigs. Am J Respir Cell Mol Biol 12: 320-328, 1995.
11. 2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest 100: 2254-2262, 1997.
12. 2 receptor dysfunction. Am J Respir Crit Care Med 163: 1484-1492, 2001.
13. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167: 199-204, 2003.
14. Frigas E, Loegering DA, Solley GO, Farrow GM, Gleich GJ. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 56: 345-353, 1981.
15. 2 muscarinic receptors in antigen-challenged guinea pig airways. J Clin Invest 99: 2036-2044, 1997.
16. 2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. J Clin Invest 90: 2292-2298, 1992.
17. Fryer AD, Jacoby DB. Muscarinic receptors and control of airway smooth muscle. Am J Respir Crit Care Med 158: S154-S160, 1998.
18. Fryer AD, Maclagan J. Ipratropium bromide potentiates bronchoconstriction induced by vagal nerve stimulation in the guinea-pig. Eur J Pharmacol 139: 187-191, 1987.
19. Fryer AD, Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 83: 973-978, 1984.
20. 2 receptor dysfunction. J Clin Invest 116: 228-236, 2006.
21. 2 muscarinic receptors in pulmonary parasympathetic nerves after antigen challenge. J Appl Physiol 71: 2255-2261, 1991.
22. Fujii T, Kawashima K. An independent non-neuronal cholinergic system in lymphocytes. Jpn J Pharmacol 85: 11-15, 2001.
23. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 51: 213-340, 1999.
24. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105: 651-663, 2000.
25. Gleich GJ, Loegering DA, Kueppers F, Bajaj SP, Mann KG. Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med 140: 313-332, 1974.
26. Gleich GJ, Loegering DA, Maldonado JE. Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med 137: 1459-1471, 1973.
27. Gleich GJ, Loegering DA, Mann KG, Maldonado JE. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest 57: 633-640, 1976.
28. Gold WM, Kessler GF, Yu DY. Role of vagus nerves in experimental asthma in allergic dogs. J Appl Physiol 33: 719-725, 1972.
29. Green CJ. Animal Anesthesia. Laboratory Animals Handbook, vol 8. London: Laboratory Animals Ltd., 1982.
30. Gross NJ. Anticholinergic agents in asthma and COPD. Eur J Pharmacol 533: 36-39, 2006.
31. Gross NJ, Skorodin MS. Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis 129: 856-870, 1984.
32. Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T, Payvandi F, Sullivan L, Zurcher JA, Watnick AS. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis 146: 263-266, 1992.
33. Gundel RH, Wegner CD, Letts LG. Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis 146: 369-373, 1992.
34. Jacoby DB, Costello RM, Fryer AD. Eosinophil recruitment to the airway nerves. J Allergy Clin Immunol 107: 211-218, 2001.
35. Jacoby DB, Fryer AD. Anticholinergic therapy for airway diseases. Life Sci 68: 2565-2572, 2001.
36. 2 receptor. J Clin Invest 91: 1314-1318, 1993.
37. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179: 881-887, 1994.
38. Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Release of granule proteins from eosinophils cultured with IL-5. J Immunol 149: 629-635, 1992.
39. Kroegel C, Giembycz MA, Barnes PJ. Characterization of eosinophil cell activation by peptides. Differential effects of substance P, melittin, and FMET-Leu-Phe. J Immunol 145: 2581-2587, 1990.
40. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356: 2144-2148, 2000.
41. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, Lenkiewicz E, Colbert D, Rinaldi L, Ackerman SJ, Irvin CG, Lee NA. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776, 2004.
42. Lefort J, Nahori MA, Ruffie C, Vargaftig BB, Pretolani M. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. J Clin Invest 97: 1117-1121, 1996.
43. Lewis DM, Loegering DA, Gleich GJ. Antiserum to the major basic protein of guinea pig eosinophil granules. Immunochemistry 13: 743-746, 1976.
44. Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams GK 3rd, Kreutner W, Egan RW, Chapman RW. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 152: 467-472, 1995.
45. McCaig DJ. Comparison of autonomic responses in the trachea isolated from normal and albumin-sensitive guinea-pigs. Br J Pharmacol 92: 809-816, 1987.
46. Minette PA, Lammers JW, Dixon CM, McCusker MT, Barnes PJ. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol 67: 2461-2465, 1989.
47. Mita H, Higashi N, Taniguchi M, Higashi A, Kawagishi Y, Akiyama K. Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge. Clin Exp Allergy 34: 931-938, 2004.
48. National Heart LaBI. Guidelines for the Diagnosis and Management of Asthma. NIH 97: 1-153, 1997.
49. Nie Z, Nelson CS, Jacoby DB, Fryer AD. Expression and regulation of ICAM-1 on airway parasympathetic nerves. J Allergy Clin Immunol. In press.
50. Noga O, Englmann C, Hanf G, Grutzkau A, Seybold J, Kunkel G. The production, storage and release of the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics and non-allergics. Clin Exp Allergy 33: 649-654, 2003.
51. Obiefuna I, Saude E, Sykes B, Adamko D. Identification of metabolic markers of asthma inflammation using 1H-NMR spectroscopy of guinea pig urine (Abstract). Proc Am Thora Soc: A485, 2006.
52. Popken-Harris P, Thomas L, Oxvig C, Sottrup-Jensen L, Kubo H, Klein JS, Gleich GJ. Biochemical properties, activities, and presence in biologic fluids of eosinophil granule major basic protein. J Allergy Clin Immunol 94: 1282-1289, 1994.
53. Pretolani M, Ruffie C, Joseph D, Campos MG, Church MK, Lefort J, Vargaftig BB. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am J Respir Crit Care Med 149: 1167-1174, 1994.
54. Ricci A, Amenta F, Bronzetti E, Mannino F, Mariotta S, Tayebati SK. Expression of peripheral blood lymphocyte muscarinic cholinergic receptor subtypes in airway hyperresponsiveness. J Neuroimmunol 129: 178-185, 2002.
55. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 161: 1862-1868, 2000.
56. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 24: 147-174, 2006.
57. Sato E, Koyama S, Okubo Y, Kubo K, Sekiguchi M. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol Lung Cell Mol Physiol 274: L970-L979, 1998.
58. Sawatzky DA, Kingham PJ, Court E, Kumaravel B, Fryer AD, Jacoby DB, McLean WG, Costello RW. Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation. Am J Physiol Lung Cell Mol Physiol 282: L1279-L1288, 2002.
59. Sheppard D, Epstein J, Holtzman MJ, Nadel JA, Boushey HA. Dose-dependent inhibition of cold air-induced bronchoconstriction by atropine. J Appl Physiol 53: 169-174, 1982.
60. Sheppard D, Epstein J, Holtzman MJ, Nadel JA, Boushey HA. Effect of route of atropine delivery on bronchospasm from cold air and methacholine. J Appl Physiol 54: 130-133, 1983.
61. Solomon A, Aloe L, Pe'er J, Frucht-Pery J, Bonini S, Bonini S, Levi-Schaffer F. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 102: 454-460, 1998.
62. Swaminathan GJ, Myszka DG, Katsamba PS, Ohnuki LE, Gleich GJ, Acharya KR. Eosinophil-granule major basic protein, a C-type lectin, binds heparin. Biochemistry 44: 14152-14158, 2005.
63. Tayebati SK, El-Assouad D, Ricci A, Amenta F. Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J Neuroimmunol 132: 147-155, 2002.
64. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 29: 88-97, 2003.
65. Verbout NG, Lorton JK, Jacoby DB, Fryer AD. A functional role for muscarinic receptors on eosinophils in the airways (Abstract). Proc Am Thorac Soc 3: A587, 2006.
66. Wagner EM, Jacoby DB. Methacholine causes reflex bronchoconstriction. J Appl Physiol 86: 294-297, 1999.
67. Ward MJ, Fentem PH, Smith WH, Davies D. Ipratropium bromide in acute asthma. Br Med J 282: 598-600, 1981.
68. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 137: 62-69, 1988.
69. Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev: CD003269, 2004.
70. Yu DY, Galant SP, Gold WM. Inhibition of antigen-induced bronchoconstriction by atropine in asthmatic patients. J Appl Physiol 32: 823-828, 1972.
71. Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 4: 1577-1590, 1990.
72. Zheng X, Knight DA, Zhou D, Weir T, Peacock C, Schellenberg RR, Bai TR. Leukemia inhibitory factor is synthesized and released by human eosinophils and modulates activation state and chemotaxis. J Allergy Clin Immunol 104: 136-144, 1999.